Cholesteryl ester transfer protein TaqIB, -629C>A and I405V polymorphisms and risk of coronary heart disease in an Indian population

Clinica Chimica Acta

Volumn 402, Issue 1-2, 2009, Pages 139-145

  Padmaja, N ^a   Kumar, Ravindra M ^a   Balachander, J ^a   Adithan, C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

CETP; CHD; Genotyping; Indian population; PCR RFLP; Polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN;

ADULT; ARTICLE; CETP B1B1 GENE; CETP TAQIB GENE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HUMAN; HYPERTENSION; INDIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX FACTORS;

EID: 60649091875     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.12.041     Document Type: Article

References (42)

1. Yen F.T., Deckelbaum R.J., Mann C.J., Marcel Y.L., Milne R.W., and Tall A.R. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest 83 (1989) 2018-2024
2. Hannuksela M.L., Liinamaa M.J., Kesaniemi Y.A., and Savolainen M.J. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110 (1994) 35-44
3. Yamashita S., Hirano K., Sakai N., and Matsuzawa Y. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochimica et Biophysica Acta 1529 (2000) 257-275
4. Drayna D., and Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucl Acids Res 15 (1987) 4698
5. Thompson J.F., Lira M.E., Durham L.K., Clark R.W., Bamberger M.J., and Milos P.M. polymorphisms in the CETP gene and association with CETP mass and HDL levels. Atherosclerosis 167 (2003) 195-204
6. Klerkx A.H., Tanck M.W., Kastelein J.J., et al. Haplotype analysis of the CETP gene: Not TaqIB, but the closely linked -629C - 1 A polymorphism and a novel promoter variant are independently associated with CETP concentration. Hum Mol Genet 12 (2003) 111-123
7. Lu H., Inazu A., Moriyama Y., et al. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J Mol Med 81 (2003) 246-255
8. Frisdal E., Klerkx A.H., Le Goff W., et al. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum Mol Genet. 14 (2005) 2607-2618
9. Boekholdt M.S., and Thompson J.F. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 44 (2003) 1080-1093
10. Dodu S.R. Coronary heart disease in developing countries: the threat can be averted. WHO Chron 38 (1984) 3-7
11. Akinkugbe O.O. Epidemiology of cardiovascular disease in developing countries. J Hypertens 8(Suppl.) (1990) S233-S238
12. Reddy K.K.R., Rao A.P., and Reddy T.P.K. Socioeconomic status and the prevalence of coronary heart disease risk factors. Asia Pac J Clin Nutr 11 (2002) 98-103
13. Enas E.A. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc 98 694-5 (2000) 697-702
14. Shenoy K.T., Lena K.B., Sali N., et al. Rationale and design for the CARDIOVIT Study (Cardiovit, atherosclerotic vascular disease and hyperhomocysteinemia: an epidemiological study in Indians, additionally evaluating the effect of oral vitamin supplementation). Curr Med Res Opin. 22 (2006) 641-648
15. Packard K.A., Majeed F., Mohiuddin S.M., Mooss A.N., Hilleman D.E., and Arouni A.J. Low high-density lipoprotein cholesterol is associated with impaired endothelial function in Asian Indians. Ethn Dis 15 (2005) 555-561
16. Blankenberg S., Rupprecht H.J., Bickel C., et al. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease. J Am Coll Cardiol 41 (2003) 1983-1989
17. Zheng K., Zhang S., Zhang L., et al. Carriers of three polymorphisms of cholesteryl ester transfer protein gene are at increased risk to coronary heart disease in a Chinese population. Int J Cardiol 103 (2005) 259-265
18. Park K.W., Choi J.H., Kim H.K., et al. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans. Clin Genet 63 (2003) 31-38
19. Brousseau M.E., O'Connor Jr. J.J., Ordovas J.M., et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: veterans Affairs HDL cholesterol intervention trial. Arterioscler Thromb Vasc Biol 22 (2002) 1148-1154
20. Boekholdt S.M., Kuivenhoven J.A., Hovingh G.K., Jukema J.W., Kastelein J.J., and van T.A. CETP gene variation: relation to lipid parameters and cardiovascular risk. Curr Opin Lipidol 15 (2004) 393-398
21. Padmaja N., Ravindra Kumar M., Soya S.S., and Adithan C. Common variants of cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population. Clin Chim Acta. 375 (2007) 140-146
22. National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation and treatment of high blood cholesterol in adults - final report. National Institutes of Health, National Heart, Lung and Blood Institute. NIH publication 2002:No.02-5215:II:1-19.
23. Povey S., Lovering R., Bruford E., Wright M., Lush M., and Wain H. The HUGO gene nomenclature committee (HGNC). Hum Genet 109 (2001) 678-680
24. Ordovas J.M., Cupples A., Corella D., et al. Association of cholesteryl ester transfer protein-Taq1B polymorphism with variations in lipoprotein subclasses and coronary heart disease risk. The Framingham study. Arterioscler Thromb Vasc Biol 20 (2000) 1323-1329
25. Blankenberg S., Tiret L., Bickel C., et al. Genetic variation of the cholesteryl ester transfer protein gene and the prevalence of coronary artery disease. The Athero Gene Case-Control Study. Z Kardiol 93 Suppl 4 (2004) IV16-23
26. Hirano K., Yamashita S., Nakajima N., et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol. 17 (1997) 1053-1059
27. Zhong S., Sharp D.S., Grove J.S., et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 97 (1996) 2917-2923
28. Bruce C., Sharp D.S., and Tall A.R. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res. 39 (1998) 1071-1078
29. Tenkanen H., Koshinen P., Kontula K., et al. Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet. 87 (1991) 574-578
30. Fumeron F., Betoulle D., Luc G., et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest 96 (1995) 1664-1671
31. Dullaart R.P.F., Hoogenberg K., Riemens S.C., et al. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes. 46 (1997) 2082-2087
32. Freeman D.J., Griffin B.A., Holmes A.P., et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: associations between the TaqIB RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb 14 (1994) 336-344
33. Borggreve S.E., Hillege H.L., Bruce H.R., et al. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher HDL cholesterol: a population based study. J Clin Endocrin Metab. 91 (2006) 3382-3388
34. Isaacs A., Sayed-Tabatabaei F.A., Hofman A., et al. The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study. Eur J Cardiovasc Prev Rehabil. 14 (2007) 419-421
35. Agerholm-Larsen B., Tybjaerg-Hansen A., Schnohr P., Steffensen R., and Nordestgaard B.G. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease. The Copenhagen City Heart Study. Circulation 102 (2000) 2197-2203
36. McCaskie P.A., Beilby J.P., Chapman C.M., et al. Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease. Hum Genet. 121 3-4 (2007) 401-411
37. Durlach A., Clavel C., Girard-Globa A., and Durlach V. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab 84 (1999) 3656-3659
38. Dachet C., Poirier O., Cambien F., Chapman J., and Rouis M. New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arterioscler Thromb Vasc Biol 20 (2000) 507-515
39. Corbex M., Poirier O., Fumeron F., et al. Extensive association analysis between the CETP gene phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 19 (2000) 64-80
40. Yusuf S., Hawken S., Ounpuu S., et al., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
41. Dixit M., Bhattacharya S., and Mittal B. Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North Indians: a case control study. BMC Endocr Disord. 5 (2005) 7
42. Winkelmann B.R., and Hager J. Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics. 1 (2000) 73-94